{"disease":{"id":"pulmonary-thromboembolism","name":"Pulmonary thromboembolism","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"fondaparinux","indication_name":"Pulmonary thromboembolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arixtra","generic_name":"FONDAPARINUX","company_name":"Mylan Ireland Ltd","drug_phase":"marketed","molecular_target":"Coagulation factor X","drug_class":"Factor Xa Inhibitor","quality_score":67,"revenue":null,"mechanism":"Arixtra works by blocking the action of factor Xa, a protein involved in blood clotting."},{"drug_id":"heparin","indication_name":"Pulmonary Thromboembolism Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"HEPARIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Anti-coagulant","quality_score":56,"revenue":null,"mechanism":"Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots."},{"drug_id":"heparin","indication_name":"Pulmonary thromboembolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"HEPARIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Anti-coagulant","quality_score":56,"revenue":null,"mechanism":"Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots."},{"drug_id":"heparin-sodium","indication_name":"Pulmonary Thromboembolism Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"Heparin Sodium","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Antithrombin III, Coagulation Factors Xa and IIa","drug_class":"Anticoagulant","quality_score":63,"revenue":null,"mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa."},{"drug_id":"heparin-sodium","indication_name":"Pulmonary thromboembolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"Heparin Sodium","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Antithrombin III, Coagulation Factors Xa and IIa","drug_class":"Anticoagulant","quality_score":63,"revenue":null,"mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa."},{"drug_id":"warfarin","indication_name":"Pulmonary Thromboembolism Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coumadin","generic_name":"warfarin","company_name":"Generic (originally Wisconsin Alumni Research Foundation)","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1-like protein 1, Cytochrome P450 2C9, Proprotein convertase subtilisin/kexin type 7","drug_class":"Vitamin K antagonist (anticoagulant)","quality_score":60,"revenue":null,"mechanism":"Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis."},{"drug_id":"warfarin","indication_name":"Pulmonary thromboembolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coumadin","generic_name":"warfarin","company_name":"Generic (originally Wisconsin Alumni Research Foundation)","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1-like protein 1, Cytochrome P450 2C9, Proprotein convertase subtilisin/kexin type 7","drug_class":"Vitamin K antagonist (anticoagulant)","quality_score":60,"revenue":null,"mechanism":"Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis."},{"drug_id":"arixtra","indication_name":"Pulmonary thromboembolism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Arixtra","company_name":"LifeBridge Health","drug_phase":"marketed","molecular_target":"Antithrombin-III, Coagulation factor X","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03660007","title":"Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer","phase":"","overall_status":"COMPLETED","enrollment_count":902891,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT02943343","title":"The China Pulmonary Thromboembolism Registry Study","phase":"","overall_status":"UNKNOWN","enrollment_count":15000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT03477968","title":"ThRombosis ExclUsion STudy","phase":"","overall_status":"TERMINATED","enrollment_count":5935,"lead_sponsor_name":"Diagnostica Stago","has_results":true},{"nct_id":"NCT04211181","title":"CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism","phase":"NA","overall_status":"RECRUITING","enrollment_count":5800,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT06341231","title":"Personalized Anticoagulant Therapy for Pulmonary Thromboembolism","phase":"","overall_status":"RECRUITING","enrollment_count":4700,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT02064439","title":"Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3365,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06382038","title":"Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2972,"lead_sponsor_name":"Navy General Hospital, Beijing","has_results":false},{"nct_id":"NCT03185377","title":"Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1708,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT03761173","title":"FlowTriever All-Comer Registry for Patient Safety and Hemodynamics","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Inari Medical","has_results":true},{"nct_id":"NCT07351435","title":"The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"University of Genova","has_results":false},{"nct_id":"NCT03134898","title":"Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension","phase":"","overall_status":"COMPLETED","enrollment_count":1025,"lead_sponsor_name":"Sociedad Española de Neumología y Cirugía Torácica","has_results":false},{"nct_id":"NCT05905874","title":"Machine Learning-based Models in Prediction of DVT and PTE in AECOPD Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT02297373","title":"Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)","phase":"","overall_status":"COMPLETED","enrollment_count":744,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":true},{"nct_id":"NCT04393909","title":"Improving Safety of Diagnosis and Therapy in the Inpatient Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05111613","title":"The PEERLESS Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":692,"lead_sponsor_name":"Inari Medical","has_results":true},{"nct_id":"NCT03595891","title":"The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung","phase":"","overall_status":"COMPLETED","enrollment_count":660,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT04168203","title":"Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT06761144","title":"Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06865326","title":"Early Detection of CTEPH in Patients After APE","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Institute of Health Information and Statistics of the Czech Republic","has_results":false},{"nct_id":"NCT05490901","title":"The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT03185845","title":"The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism","phase":"NA","overall_status":"UNKNOWN","enrollment_count":392,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT03134820","title":"Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease","phase":"","overall_status":"COMPLETED","enrollment_count":352,"lead_sponsor_name":"Delos Clinical","has_results":false},{"nct_id":"NCT05351749","title":"Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use","phase":"NA","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT06348459","title":"Registry of Catheter Intervention in Pulmonary Embolism","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT02585713","title":"Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT06194617","title":"Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04859478","title":"Venous Phase Dual Energy CT in Patients Suspected for Pulmonary Embolism.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Copenhagen University Hospital at Herlev","has_results":false},{"nct_id":"NCT01513759","title":"Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Boston Scientific Corporation","has_results":true},{"nct_id":"NCT07132619","title":"Kidney Injury After PTE: Association With Hypothermic Circulatory Arrest Duration","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Ebru Girgin Dinc","has_results":false},{"nct_id":"NCT03183063","title":"Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events","phase":"NA","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"Thomas Guerrero","has_results":true},{"nct_id":"NCT06189313","title":"CLEANer Aspiration for Pulmonary Embolism","phase":"NA","overall_status":"SUSPENDED","enrollment_count":125,"lead_sponsor_name":"Argon Medical Devices","has_results":false},{"nct_id":"NCT02616991","title":"Computed Tomography CT Venography During Postpartum Venous Thromboembolism","phase":"NA","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04795167","title":"FlowTriever for Acute Massive Pulmonary Embolism (FLAME)","phase":"","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Inari Medical","has_results":true},{"nct_id":"NCT06062329","title":"SYMPHONY-PE Study for Treatment of Pulmonary Embolism","phase":"NA","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Imperative Care, Inc.","has_results":false},{"nct_id":"NCT05172115","title":"Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":94,"lead_sponsor_name":"Rajaie Cardiovascular Medical and Research Center","has_results":false},{"nct_id":"NCT05891886","title":"Supplemental Oxygen in Pulmonary Embolism (SO-PE)","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04813575","title":"COVID-19 Pathophysiology of Long Term Implications","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"King Faisal Specialist Hospital & Research Center","has_results":false},{"nct_id":"NCT07290608","title":"DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"ITALO EUGENIO SOUZA GADELHA DE ABREU","has_results":false},{"nct_id":"NCT06392672","title":"Evaluation of the Effect of Drug-Related Problems in Pulmonary Embolism","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Bezmialem Vakif University","has_results":false},{"nct_id":"NCT03070834","title":"RIPT Feasibility Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT05719415","title":"Functional Pulmonary Capillary Surface Area in BPA for CTEPH","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Jewish General Hospital","has_results":false},{"nct_id":"NCT03197792","title":"Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":39,"lead_sponsor_name":"Centre Chirurgical Marie Lannelongue","has_results":false},{"nct_id":"NCT03581877","title":"Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":31,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT06886516","title":"Apixaban in Thrombocytopenia","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Rushad Patell","has_results":false},{"nct_id":"NCT04625673","title":"OsciPulse Device for the Prevention of VTE","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT03516656","title":"Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT02970032","title":"Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Utah","has_results":true},{"nct_id":"NCT04022915","title":"PET Fibrin Imaging of DVT and PE","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Peter Caravan","has_results":true},{"nct_id":"NCT05992168","title":"Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Suzhou Zenith Vascular Scitech Co., Ltd.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}